Creo Medical Group Plc (CREO) Ord GBP0.001

- Add to watchlist
- Create an alert
- This stock can be held in a




32.25p
32.50p
38.75p
£116.50 million
32.10p
32.00p
19.08p
n/a
0.15p (0.47%) Previous:
0.15p
105,847
n/a
5,000
Performance
Not available for this stock.
Fundamental data
Year ending: | 31/12/2022 | 31/12/2021 |
---|---|---|
Revenue (£m) | 27.17 | 25.16 |
Profit before tax (£m) | (30.98) | (30.34) |
Adjusted EPS (p): | (14.48) | (14.48) |
P/E ratio | n/a | n/a |
PEG | n/a | n/a |
EPS growth (%) | n/a | n/a |
Values are quoted in the stock's local currency: British pound
All fundamental dataDividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
Important Documents
There are no documents available for this stock.
-
Creo Medical gets US FDA clearance for Speedboat UltraSlim
1 November 2023 14:28
-
Creo Medical accelerating EU launch of Speedboat UltraSlim
25 October 2023 13:44
-
Creo Medical's 'Speedboat Inject' used for first time in Europe
26 June 2023 10:35
-
Capital Markets Day
7 November 2023 07:00
-
Speedboat® UltraSlim: US FDA Clearance
1 November 2023 07:00
-
SB UltraSlim: EU launch accelerated by 18 months
25 October 2023 07:00
Recent trade data is unavailable. We will be replacing it, however in the meantime the information is available on the London Stock Exchange website.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.